The Impact of Biologics for the Management of Inflammatory Bowel Disease on Liver Enzymes

Elizabeth S. Aby; John R. Lake; Byron P. Vaughn

doi:10.1002/cld.1005

The Impact of Biologics for the Management of Inflammatory Bowel Disease on Liver Enzymes

Elizabeth S. Aby, John R. Lake, Byron P. Vaughn

Medicine - Gastro, Hepatology, Nutrition Division

Research output: Contribution to journal › Review article › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	212-217
Number of pages	6
Journal	Clinical Liver Disease
Volume	16
Issue number	5
DOIs	https://doi.org/10.1002/cld.1005
State	Published - Nov 2020

Access

10.1002/cld.1005

OpenUrl availability

Full text

Cite this

@article{050c0e7b2f554b4ba54ebefb31907a89,

title = "The Impact of Biologics for the Management of Inflammatory Bowel Disease on Liver Enzymes",

author = "Aby, {Elizabeth S.} and Lake, {John R.} and Vaughn, {Byron P.}",

year = "2020",

month = nov,

doi = "10.1002/cld.1005",

language = "English (US)",

volume = "16",

pages = "212--217",

journal = "Clinical Liver Disease",

issn = "2046-2484",

publisher = "John Wiley and Sons Ltd",

number = "5",

}

TY - JOUR

T1 - The Impact of Biologics for the Management of Inflammatory Bowel Disease on Liver Enzymes

AU - Aby, Elizabeth S.

AU - Lake, John R.

AU - Vaughn, Byron P.

PY - 2020/11

Y1 - 2020/11

UR - http://www.scopus.com/inward/record.url?scp=85097488437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85097488437&partnerID=8YFLogxK

U2 - 10.1002/cld.1005

DO - 10.1002/cld.1005

M3 - Review article

C2 - 33318791

AN - SCOPUS:85097488437

SN - 2046-2484

VL - 16

SP - 212

EP - 217

JO - Clinical Liver Disease

JF - Clinical Liver Disease

IS - 5

ER -

The Impact of Biologics for the Management of Inflammatory Bowel Disease on Liver Enzymes

Access

OpenUrl availability

Other files and links

Cite this